Clinical Trial Update: Efficacy and Safety Assessment of ZOlpidem (Stilnox CR) in Patients With Chronic insomNIA [Phase 4]

View source ↗

Summary

Phase 4 trial by Sanofi assesses the efficacy and safety of zolpidem CR (Stilnox CR) for chronic insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Stilnox CR (zolpidem)

Snippet

Sponsor: Sanofi | Conditions: Sleep Disorders | Phase 4 | Status: COMPLETED